Same-day Long-acting Reversible Contraception for Medication Abortion

Etonogestrel Implant or Depot Medroxyprogesterone Acetate for Medication Abortion

NCT01356927•Boston University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Abortion; Induced

Interventions

DMPA

Etonogestrel implant

Locations

United States

Locations (1)

Boston University Medical Center

Boston, Massachusetts, United States

Key Dates

Start Date

May 1, 2011

Primary Completion Date

April 1, 2014

Completion Date

April 1, 2014

Last Updated

April 7, 2017

Sponsors

Lead Sponsor

Boston University

Collaborators

Family Planning Fellowship

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 7, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions